Features
Severe asthma is a challenging condition. Available therapeutic options for severe asthma include tiotropium, omalizumab, interleukin-5 targeted therapies, macrolide antibiotics, and bronchial thermoplasty.
Features
The Global Initiative for Asthma (GINA)'s 2012 Guidelines provides a stepwise plan for treatment of asthma, based on disease severity.
Features
The most recent guidelines from the American College of Rheumatology
include pharmacologic and nonpharmacologic therapy for hyperuricemia.
Features
In 2013, approximately 84% of households in the United States reported detectable levels of dust mite allergens.
Features
The Centers for Disease Control and Prevention (CDC) classifies key biological agents into three categories: A, B, and C.
Features
Medications can induce HTN through a variety of mechanisms such as volume retention, sympathomimetic activation, and direct vasoconstriction.
Features
The 10-step program assists clinicians in diagnosing and treating CDH.
Features
In addition to clinical presentation, the choice of treatment also depends on patient-related factors, such as age, concomitant co-morbidities, and patient preferences.
Features
What are the comparative benefits and harms of different pharmacologic therapies?
Features
Because individuals with existing cardiovascular disease (CVD) may be at particular risk for cardiovascular events if they use nonsteroidal anti-inflammatory drugs (NSAIDs), a recent article reviews the safety of NSAIDs in general, and particularly in this population.
